Register Interest

Registration is Now Closed for the Supply Chain & Logistics for Cell & Gene Therapies Summit

Thank you to our speakers, sponsors and delegates for joining us!

Register your interest for next year's meeting below to be kept up to date on all relevant news and announcements including agenda release, speaker line-up, sponsorship opportunities, and first-release tickets.

Attendees in 2025 Included

6th Supply Chain and Logistics for Cell Therapies, AstraZeneca, Autolus, Arsenalbio, Beam Therapeutics
6th Supply Chain and Logistics for Cell Therapies, ICCBBA, Legend Biotech, Modality Solutions. Moffitt Cancer Center, Novartis
6th Supply Chain and Logistics for Cell Therapies, Orchard Therapeutics, QuickStat, TrakCel, Vertex Pharmaceuticals
6th Supply Chain and Logistics for Cell Therapies, Regenxbio, t-knife therapeutics, cencora world courier
6th Supply Chain and Logistics for Cell Therapies, Fate, Resolution therapeutics, carsgen, generate bioscience
6th Supply Chain and Logistics for Cell Therapies, Aurion Biotech, Vor Biopharma, Genentech, BioBridge Global
6th Supply Chain and Logistics for Cell Therapies, Galapagos, Fufifilm Diosynth, Queel Therapeutics, BlueRock

Explore Related Cell Therapy Products

 

Cell Therapy


Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale

Conferences

Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.

Data 

Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.

Networking

A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors. 

Research

A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.